External Urine Management Products Market Size, Share and Growth Outlook, 2026

External Urine Management Products Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global External Urine Management Products Market size is forecast to increase from $52.03 Billion in 2026 to $86.11 Billion in 2034 at a CAGR of 6.5% between 2026 and 2034.

The External Urine Management Products market report provides detailed analysis and outlook of External Urine Management Products segments including By Product Type (Male External Catheters, Female External Catheters, Urine Collection Accessories, External Urine Collection Devices ), By Category (Disposable Products, Reusable Products), By Distribution Channel (Online Distribution, Offline Distribution ), By End-User (Hospitals and Clinics, Home Care Settings, Nursing Homes and Long-term Care Facilities, Diagnostic Laboratories) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

External Urine Management Products Industry Overview

Clinical Validation Supporting High-Efficiency External Urine Collection Systems in Home Care Settings

The external urine management products industry is advancing through clinically validated non-invasive systems designed to improve urinary incontinence management while reducing complications associated with indwelling catheters. A multi-center randomized controlled trial published in MDPI Diagnostics evaluated the PureWick™ System against a comparator external urine collection device for nocturnal urinary incontinence in home care environments. The study demonstrated non-inferiority performance, with the suction-based system achieving an average overnight urine capture rate of 90.9% across 165 female participants in 13 clinical sites, with no adverse-event-related dropouts. These findings reinforce the clinical viability of external suction-based urine management systems as effective alternatives for long-term incontinence care, particularly in non-hospital settings where patient comfort and infection prevention are critical outcomes.

Infection Prevention Strategies Driving Adoption of Non-Invasive Male External Collection Devices

The external urine management products industry is increasingly driven by infection control priorities and the transition away from indwelling catheter use in acute and long-term care environments. Medline Industries, Inc. expanded clinical deployment of the QiVi MEC male external urine management device through an exclusive distribution partnership with Consure Medical. The suction-assisted system is designed to rapidly isolate moisture, reducing exposure duration and supporting nursing workflows aimed at lowering catheter-associated urinary tract infections (CAUTIs) and incontinence-associated dermatitis (IAD). These non-invasive external systems are being integrated into hospital protocols as part of broader infection prevention strategies that prioritize skin-safe, low-risk urinary diversion solutions. The growing adoption of external urine management technologies reflects increasing institutional focus on patient safety, hygiene optimization, and complication reduction in continence care pathways.

Healthcare Policy Expansion Enabling Wider Access to External Urine Management Technologies

The external urine management products industry is also being shaped by reimbursement policy enhancements that improve patient access to advanced continence care solutions. The Centers for Medicare & Medicaid Services (CMS) updated Durable Medical Equipment (DME) Medicare Administrative Contractor supplier manuals to expand coverage criteria for external urine collection systems, including FDA-registered external condom catheter devices. This policy revision reduces financial barriers for patients managing chronic urinary incontinence and supports broader adoption of external, non-invasive alternatives to indwelling catheters. The shift in reimbursement frameworks is accelerating the transition toward safer urinary management technologies that reduce infection risks while improving patient comfort and mobility in both home and institutional care settings.

External Urine Management Products Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global External Urine Management Products market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Becton, Dickinson and Company (BD) (C.R. Bard), Coloplast A/S, Hollister Incorporated, Teleflex Incorporated, Stryker Corporation (Sage Products), Cardinal Health, Inc., B. Braun Melsungen AG, Consure Medical, Tilla Care Ltd., BioDerm, Inc. (Men's Liberty). The External Urine Management Products market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the External Urine Management Products industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth External Urine Management Products Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by External Urine Management Products companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional External Urine Management Products markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

External Urine Management Products Market Competitive Benchmarking and Company Analysis

Leading companies in External Urine Management Products industry include- Becton, Dickinson and Company (BD) (C.R. Bard), Coloplast A/S, Hollister Incorporated, Teleflex Incorporated, Stryker Corporation (Sage Products), Cardinal Health, Inc., B. Braun Melsungen AG, Consure Medical, Tilla Care Ltd., BioDerm, Inc. (Men's Liberty). The External Urine Management Products market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US External Urine Management Products Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the External Urine Management Products market remains one of the strongest-performing segments in the country.
The US External Urine Management Products Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US External Urine Management Products market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across External Urine Management Products industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian External Urine Management Products markets

Canada's strong External Urine Management Products sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian External Urine Management Products market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany External Urine Management Products Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest External Urine Management Products market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of External Urine Management Products population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany External Urine Management Products industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the External Urine Management Products market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support External Urine Management Products sales through 2034

France External Urine Management Products companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK External Urine Management Products Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of External Urine Management Products distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China External Urine Management Products Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China External Urine Management Products market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of External Urine Management Products industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese External Urine Management Products industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India External Urine Management Products Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian External Urine Management Products market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil External Urine Management Products market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa External Urine Management Products Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

External Urine Management Products Market Segmentation

By Product Type
Male External Catheters
Female External Catheters
Urine Collection Accessories
External Urine Collection Devices
By Category
Disposable Products
Reusable Products
By Distribution Channel
Online Distribution
Offline Distribution
By End-User
Hospitals and Clinics
Home Care Settings
Nursing Homes and Long-term Care Facilities
Diagnostic Laboratories

Top Companies in External Urine Management Products Industry

Becton, Dickinson and Company (BD) (C.R. Bard)
Coloplast A/S
Hollister Incorporated
Teleflex Incorporated
Stryker Corporation (Sage Products)
Cardinal Health, Inc.
B. Braun Melsungen AG
Consure Medical
Tilla Care Ltd.
BioDerm, Inc. (Men's Liberty)

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Low MOQ, High-Mix Production Models for Indie & DTC Brands

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025